The Global Adrenomyeloneuropathy Treatment Market is expected to grow with a CAGR of 12% during the forecast period 2022-2028. Adrenomyeloneuropathy is a rare hereditary neurodegenerative disease. Adrenospinal neuropathy is an adult onset of adrenal leukodystrophy caused by mutations in the ABCD1 gene and usually occurs in young boys. Adrenal spinal neuropathy affects nerve cells in […]
